sub:provenance {
  sub:assertion dcterms:description "[We found that, unlike benzo[a]pyrene trans-7,8-dihydrodiol-9,10-epoxide-DNA adduction, which preferentially occurs at CpG sites, 4-ABP-DNA adduction is not biased for CpG sites, and the adducts are more evenly distributed along the p53 gene; nonetheless, the p53 mutational hotspots in bladder cancer at codons 175, 248, 280 and 285 are also the preferential sites for 4-ABP adduct formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    
wi:evidence dgn-void:source_evidence_literature ;
    
sio:SIO_000772 miriam-pubmed:12376482 ;
    
prov:wasDerivedFrom dgn-void:BEFREE ;
    
prov:wasGeneratedBy eco:ECO_0000203 . 
  
dgn-void:BEFREE pav:importedOn "2017-02-19"^^
xsd:date . 
  
dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    
rdfs:label "DisGeNET evidence - LITERATURE"@en . 
}